misonidazole has been researched along with Central Nervous System Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 3 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gangji, D; Koziol, D; Partington, J; Phillips, TL; Schwade, JG; Strong, JM; Urtasun, R; Van Raalte, G; Wasserman, TH | 1 |
Johnson, RJ; Levin, VA; Phillips, TL; VanRaalte, G; Wasserman, TH | 1 |
Kehrberg, G; Moldenhauer, H; Rose, H; Saul, G; Wolf, G | 1 |
1 review(s) available for misonidazole and Central Nervous System Diseases
Article | Year |
---|---|
[Modification of the radiation effects for overcoming radiation-resistant hypoxic tumor tissue].
Topics: Amifostine; Animals; Central Nervous System Diseases; Dogs; Humans; Hyperthermia, Induced; In Vitro Techniques; Intestines; Lymphocytes; Metronidazole; Mice; Misonidazole; Neoplasms; Neoplasms, Experimental; Nerve Tissue; Nitro Compounds; Oxygen; Radiation Dosage; Radiation-Protective Agents; Radiation-Sensitizing Agents; Rats | 1983 |
2 other study(ies) available for misonidazole and Central Nervous System Diseases
Article | Year |
---|---|
The neurotoxicity of misonidazole: potential modifying role of phenytoin sodium and dexamethasone.
Topics: Central Nervous System Diseases; Dexamethasone; Drug Interactions; Half-Life; Humans; Misonidazole; Nitroimidazoles; Peripheral Nervous System Diseases; Phenytoin | 1980 |
Final report on the United States Phase I Clinical Trial of the hypoxic cell radiosensitizer, misonidazole (Ro-07-0582; NSC #261037).
Topics: Adolescent; Adult; Aged; Central Nervous System Diseases; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Female; Hearing Loss; Humans; Male; Middle Aged; Misonidazole; Nausea; Nitroimidazoles; Peripheral Nervous System Diseases; Vomiting | 1981 |